Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Letibotulinumtoxina - Hugel

Next Previous
Search
Drug Profile

Letibotulinumtoxina - Hugel

Alternative Names: BoNT/A-DP; Botulax; Botulinum toxin type A - Hugel; HG-102; Letybo

Latest Information Update: 06 Mar 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hugel
  • Developer Croma Pharma; Hugel
  • Class Antispasmodics; Bacterial proteins; Bacterial toxins; Botulinum toxins; Muscle relaxants; Skin disorder therapies
  • Mechanism of Action Acetylcholine inhibitors; Glutamate antagonists; Neuromuscular blocking agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Blepharospasm; Glabellar lines
  • Phase III Cerebral palsy; Facial wrinkles
  • Phase II Hypertrophy
  • No development reported Overactive bladder; Torticollis

Most Recent Events

  • 04 Mar 2024 Registered for Glabellar lines (In the elderly, In adults) in USA (IM)
  • 04 Mar 2024 Hugel announces intention to launch letiboltulinumtoxina for Glabellar lines in USA in first half of 2024
  • 31 Dec 2023 Launched for Glabellar lines (In adults) in Canada (IM) prior to December 2023

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top